Cite
Lovastatin enhances paraoxonase enzyme activity and quells low-density lipoprotein susceptibility to oxidation in type 2 diabetic nephropathy
MLA
Nezami, Nariman, et al. “Lovastatin Enhances Paraoxonase Enzyme Activity and Quells Low-Density Lipoprotein Susceptibility to Oxidation in Type 2 Diabetic Nephropathy.” Clinical Biochemistry, vol. 44, no. 2/3, Feb. 2011, pp. 165–70. EBSCOhost, https://doi.org/10.1016/j.clinbiochem.2010.10.006.
APA
Nezami, N., Ghorbanihaghjo, A., Argani, H., Safa, J., Rashtchizadeh, N., Vatankhah, A. M., Salari, B., & Hajhosseini, B. (2011). Lovastatin enhances paraoxonase enzyme activity and quells low-density lipoprotein susceptibility to oxidation in type 2 diabetic nephropathy. Clinical Biochemistry, 44(2/3), 165–170. https://doi.org/10.1016/j.clinbiochem.2010.10.006
Chicago
Nezami, Nariman, Amir Ghorbanihaghjo, Hassan Argani, Javid Safa, Nadereh Rashtchizadeh, Amir Mansour Vatankhah, Behzad Salari, and Babak Hajhosseini. 2011. “Lovastatin Enhances Paraoxonase Enzyme Activity and Quells Low-Density Lipoprotein Susceptibility to Oxidation in Type 2 Diabetic Nephropathy.” Clinical Biochemistry 44 (2/3): 165–70. doi:10.1016/j.clinbiochem.2010.10.006.